Industry News - Tag: Ranitidine

You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Zantac recall hits Sanofi Consumer Healthcare
Premium

12 February 2020

Sanofi's Consumer Healthcare business reported worldwide sales down by 5.2% at constant exchange rates in the fourth quarter of 2019. The company said the fall was due to the voluntary recall of Zantac (ranitidine), non-core brand divestments, and product suspensions due to changing regulatory requi...

Read the full story

Zantac recall, divestments and regulations curb Sanofi
Premium

8 November 2019

Sanofi's Consumer Healthcare business reported worldwide sales up by 0.4% at constant exchange rates in the third quarter of 2019. The company said growth had been curbed by a voluntary recall of Zantac, non-core brand divestments, and tightening regulatory requirements, particularly in Europe.

Read the full story